This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by AONO, T. Articles by KURACHI, K. Search for Related Content PubMed PubMed Citation Articles by AONO, T. Articles by KURACHI, K.

Impaired LH Release Following Exogenous Estrogen Administration in Patients with Amenorrhea-Galactorrhea Syndrome

Department of Obstetrics and Gynecology, and Central Laboratory for Clinical Investigation Fukushima-ku Osaka 553, Japan
^* Osaka University Medical School Fukushima-ku Osaka 553, Japan

Serum gonadotropin levels were determined in 10 patients with the amenorrhea-galactorrhea syndrome before and following acute iv administration of synthetic LH-releasing hormone (LHRH) or conjugated estrogens, in order to clarify the hypothalamic derangements in the gonadotropin secretion in patients with hyperprolactinemia. The basal prolactin (PRL) levels were elevated in all the patients, and blunted responses to 500 µg of iv synthetic thyrotropin-releasing hormone (TRH) injection were found in 9 out of the 10 patients! The basal levels of LH and FSH were subnormal in 2 and 3 patients, respectively, while those in the remaining patients were normal or slightly elevated. Normal or excessive responses of gonadotropins to 100 µg of iv LHRH were observed in most patients, 9 for LH and 10 for FSH out of 10 patients. In 10 normal cyclic women at the midfollicular phase (D_7–9) and 10 hypothalamic amenorrhea patients without galactorrhea, LH release was found 48 to 72 h after the iv injection of 20 mg conjugated estrogens (Premarin). This LH release following Premarin injection was completely abolished in the patients with amenorrhea-galactorrhea. These data seem to indicate that in patients with hyperprolactinemia, tonic secretion of gonadotropin is maintained fairly well, while the positive feedback effect of Premarin on the release of LH is impaired. It is suggested that impaired LH release may be partly responsible for anovulation and amenorrhea in patients with hyperprolactinemia.

Received June 4, 1975.

This article has been cited by other articles:

				C. B. Hammond and S. J. Ory Diagnostic and Therapeutic Uses of Gonadotropin-Releasing Hormone Arch Intern Med, September 1, 1985; 145(9): 1690 - 1697. [Abstract] [PDF]

				V. S. LIM, C. HENRIQUEZ, G. SIEVERTSEN, and L. A. FROHMAN Ovarian Function in Chronic Renal Failure: Evidence Suggesting Hypothalamic Anovulation Ann Intern Med, July 1, 1980; 93(1_Part_1): 21 - 27. [Abstract] [PDF]